( Last Updated : December 8, 2020)
Generic Name:
Project Status:
Therapeutic Area:
Prevention of pregnancy
Merck Canada Inc.
Call for patient/clinician input open:
Brand Name:
Project Line:
Reimbursement Review
Project Number:
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC


Manufacturer Requested Reimbursement Criteria1:
Indicated for the prevention of pregnancy for up to 3 years
Submission Type:
Fee Schedule:
Schedule A
Indicated for the prevention of pregnancy for up to 3 years
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.

Key Milestones2

Call for patient input open May 06, 2020
Call for patient input closed June 25, 2020

- No patient input submission received

Submission received June 03, 2020

Submission was previously withdrawn and has been refiled by the sponsor


Submission accepted June 17, 2020
Review initiated June 18, 2020
Draft CADTH review report(s) provided to sponsor for comment July 31, 2020
Deadline for sponsors comments August 12, 2020
CADTH responses on draft review report(s) provided to sponsor September 03, 2020
Expert committee meeting (initial) September 16, 2020
Draft recommendation issued to sponsor September 28, 2020
End of embargo period October 13, 2020
Final recommendation issued to sponsor and drug plans October 20, 2020
Final recommendation posted October 22, 2020
Deadline for sponsor to submit redaction requests on draft CADTH review report(s) November 03, 2020
CADTH review report(s) posted December 07, 2020